US 7141434
Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing an adenosine kinase
granted A61KA61K31/00A61K31/7076
Quick answer
US patent 7141434 (Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing an adenosine kinase) held by Rigel Pharmaceuticals, Inc. expires Mon Nov 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Nov 28 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 23 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61K, A61K31/00, A61K31/7076